Dallas, Texas – Jan 19, 2014 - North American Cannabis Holdings, Inc. (USMJ) today announced ongoing discussions with a Texas based, certified NFL agent in conjunction with the coming launch of a proprietary cannabis infused therapeutic supplement. In light of the recent risks facing football players made very public by Will Smith’s recent movie ‘Concussion’, many current and former NFL players are now advocates for medical marijuana.
The company has formulated an anti-inflammatory supplement derived from the extraction of cannabidiol (CBD) from the hemp strain of the cannabis plant. The product contents and production process are designed with the intent of remaining well within all current state and federal regulations and laws.
The cannabis anti-inflammatory remedy is part of an overall sports and fitness nutritional supplement line recently introduced by the Company. The Company anticipates adding sales in the first calendar quarter of 2016 from the new product line that will in turn add to the Company’s existing retail cafe sales. Two online presentations have been published on the Company’s website providing more detail on the Sports and Fitness Nutritional Supplements Line:
The Company maintains ongoing analyst coverage. The independent analyst recently upgraded the ongoing analyst coverage to a ‘buy recommendation’ with an increased PPS target. The full report is available at the link below:
About North American Cannabis Holdings, Inc.
North American Cannabis Holdings, Inc. (USMJ) is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. For more information please visit http://www.growusmj.com.
Follow the company on Twitter: http://twitter.com/US_HEMP.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.